Oedema Recruiting Phase 2 Trials for Atezolizumab (DB11595)

Also known as: Edema / Edema NOS / Oedema NOS / Edema (NOS) / Fluid retention NOS

IndicationStatusPhase
DBCOND0012174 (Oedema)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03202316Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast CancerTreatment